We already know that small options traders, among many others, have been jumping once again into speculative trades. Now we can add hedge funds to the...
Faced with a looming mental health crisis, the UK government has been urged to invest in the digitisation The post Digitisation key to improving mental health...
The FDA has added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the shot has The post FDA adds warning of rare neurological...
Beijing has obtained a trade surplus of $252.7 billion thanks to the strong increase in exports, how will this impact the global markets?
Pfizer and its partner, BioNTech, announced a few days ago that they plan to ask U.S. and European regulators to authorize a booster dose of their...
COVID-19 vaccination produces a more consistent immune response than a past infection. With the delta variant, the difference in protection may be even greater.
While a retest of the multi-year low around ¥6.36 doesn’t seem likely in the immediate future, a movement above the... The post Weekly forex data: inflation...
Bitcoin moved inversely to the dollar at the beginning of this week as traders awaited the June CPI report due Tuesday. Bitcoin (BTC) prices steadied on...
With more variants of the coronavirus spreading, could these health care names be top buys now? The post 3 Health Care Stocks To Watch This Week...
Could fortune favor the bold when it comes to these meme stocks? The post Best Meme Stocks To Buy This Week? 3 In Focus appeared first...
When we think about MBS, it’s the historical downtrend in bond yields that matters, not federal debt and not tapering. HW+ Premium Content The post For...
Israel is partnering with U.S.-based NRx Pharmaceuticals to complete trials and commercialize the Israeli-developed Covid-19 vaccine BriLife.
A World Health Organization (WHO) committee said on July 12 that human genome editing technologies to treat serious disease should be shared more generously, to allow...
The U.S. Food and Drug Administration is planning a new warning for Johnson & Johnson’s Covid-19 vaccine over a rare but serious side effect, Guillain-Barré syndrome...
Health agencies and vaccine and immunology experts have pushed back against Pfizer and BioNTech’s assertions that a Covid-19 booster shot is necessary.